Nanotechnology transforming drug delivery with sustained-release implantable devices. The company develops innovative drug-delivery solutions using its proprietary nanofluidics platform. Their implantable devices offer long-term, constant release of various drugs and biologics, including small molecules, peptides, and proteins. The technology utilizes state-of-the-art semiconductor manufacturing methods and biocompatible materials to create a tunable array of nanochannels that regulate drug deli Founded in 2007, headquartered in Austin, United States. The company has raised $7.2M at the Series A stage backed by investors including U.S Army, Military Health, National Science Foundation, Wilkes Lane Capital, Capital Factory. Operating in High Tech > Nanotechnology, Life Sciences > Drug Delivery.
← All startups
NanoMedical Systems
Series ANanotechnology transforming drug delivery with sustained-release implantable devices. The company develops innovative drug-delivery solutions using its proprietary nanofluidics platform. Their implantable devices offer long-term, constant release of various drugs and biologics, including small molecules, peptides, and proteins. The technology utilizes state-of-the-art semiconductor manufacturing methods and…
About
Business model
Nanotechnology > Nanoenabled Products > Life Science > Drug Delivery > Encapsulation,
Drug Delivery > Implants
Institutional investors
U.S ArmyMilitary HealthNational Science FoundationWilkes Lane CapitalCapital FactoryCentral Texas Angel Network
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Investor directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.